Table 1 Patient characteristics according to baseline MPV levels
|  | MPV<10.5 fL | MPV ≥10.5 fL) | t/χ2 | P |
|---|---|---|---|---|
Male | 33 (70.2) | 38 (80.9) | 1.439 | 0.230 |
Age (year) | 55.04 ± 13.13 | 56.60 ± 9.42 | 0.659 | 0.512 |
Hypertension | 19 (40.4) | 26 (55.3) | 2.089 | 0.148 |
Diabetes mellitus | 14 (29.8) | 23 (48.9) | 3.610 | 0.057 |
Smoking | 27 (57.4) | 30 (63.8) | 0.401 | 0.527 |
Drinking | 6 (12.8) | 12 (25.5) | 2.474 | 0.116 |
Family history of CAD | 6 (12.8) | 10 (21.3) | 1.205 | 0.272 |
Previous myocardial infarction | 8 (17.0) | 7 (14.9) | 0.079 | 0.778 |
Previous PCI | 7 (14.9) | 14 (29.8) | 3.005 | 0.083 |
BMI | 24.40 ± 3.2 | 25.92 ± 3.92 | 2.052 | 0.043 |
HDL-c (mmol/l) | 1.03 ± 0.25 | 0.92 ± 0.25 | 2.149 | 0.034 |
LDL-c (mmol/l) | 2.28 ± 0.8 | 2.63 ± 0.84 | 2.075 | 0.041 |
TC (mmol/l) | 3.63 ± 0.92 | 3.75 ± 1.1 | 0.560 | 0.577 |
TG (mmol/l) | 1.81 ± 0.93 | 1.8 ± 0.94 | 0.069 | 0.946 |
ApoA1 (g/L) | 1.14 ± 0.25 | 1.03 ± 0.28 | 2.118 | 0.037 |
ApoB (g/L) | 0.71 ± 0.17 | 0.86 ± 0.21 | 3.722 | < 0.001 |
Lp(a) (g/L) | 191 (100,292) | 205 (98,363) | 0.502 | 0.616 |
Creatinine (μmol/L) | 76.30 ± 18.66 | 80.72 ± 18.5 | 1.152 | 0.252 |
Carbamide (mmol/l) | 5.23 ± 1.58 | 5.58 ± 1.73 | 1.016 | 0.312 |
eGFR | 114.17 ± 36.99 | 101.1 ± 35.68 | 1.744 | 0.085 |
Uric acid (μmol/L) | 315.93 ± 103.6 | 348.14 ± 83.14 | 1.663 | 0.100 |
EF | 60.68 ± 8.05 | 59.71 ± 8.84 | 0.546 | 0.586 |
HbA1c (mmol/l) | 7.23 ± 1.34 | 7.24 ± 1.4 | 0.048 | 0.962 |
Clinical Diagnosis | Â | Â | 0.047 | 0.829 |
 UAP | 31 (66.0) | 30 (63.8) |  |  |
 NSTEMI | 16 (34.0) | 17 (36.2) |  |  |
Medications | ||||
 Aspirin | 37 (78.7) | 32 (68.1) | 1.362 | 0.243 |
 Statins | 11 (23.4) | 16 (34.0) | 1.299 | 0.254 |
 β-Blockers | 16 (34.0) | 16 (34.0) | 0.000 | 1.000 |
 ACEI/ARB | 14 (29.8) | 22 (46.8) | 2.881 | 0.090 |
 CCB | 11 (23.4) | 11 (23.4) | 0.000 | 1.000 |
 GRACE risk score | 102.07 ± 31.11 | 109.03 ± 21.24 | 1.001 | 0.321 |